Gambaran Hasil Skrining Infeksi Menular Lewat Transfusi Darah (IMLTD) Pendonor di Unit Donor Darah (UDD) PMI Kabupaten Kudus Tahun 2021-2022

Abstract

Blood transfusion is an important form of health care. Giving according to indications can save lives and improve health status. Even so, giving blood transfusions carries the risk of transmitting various infectious diseases through blood transfusions (TTI), especially HIV/AIDS, Hepatitis C, Hepatitis B, Syphilis. This type of research is a descriptive study with a cross-sectional survey design with a sampling technique using secondary data on the total population. From a sample of 18,711 samples, TTI reactive results were examined from donor data to be included as research subjects. From the available data, the examination was carried out by combining the rapid test method with the Chemiluminescence (ChLia) method in the 2021 and 2022 periods. The 2021 research period was TTI reactive with parameters Anti HbSAg 0.07%, Anti HCV 0.04%, Anti HIV 5.34%, and RPR ( syphilis) 10.15%. While the 2022 study period was reactive TTI with parameters Anti HbSAg 0.07%, Anti HCV 0.11%, Anti HIV 5.34%, and RPR (syphilis) 5.59%. The percentage of TTI reactive numbers in 2021 will be lower, in 2022 it will increase. The TTI examination is a requirement for donated blood so that disease transmission does not occur from the donor to the recipient. TTI that must be examined according to regulations in Indonesia include HIV, HBsAg, HCV, and syphilis.